Biobanking 2018

DESCRIPTION

On 22 & 23 March 2018, Porto will host the 1st BioTech Pharma Summit: Biobanking 2018. This year event will bring together the world’s leading experts in biorepositories, policy makers, and scientific actors to strengthen knowledge in biobanking as well as explore future advances in the field of biosampling for precision medicine, drug development and health research.

The biobanking market is expected to reach USD 2.69 Billion by 2022 from USD 1.72 Billion in 2016 at a CAGR of 7.8%

Our distinguished panel includes renowned clinicians, researchers, executives and technical professionals from the biopreservation industry as well as the pioneers for a worldwide human research resource. Moreover, the current era is flooded with new advanced technologies, which culminated with the proliferation of more Biobank institutes globally, acting as a clear indicator of a market growth in the field.

We invite all the participants across the globe to join our scientific gathering, which aims to reveal the newest data and share innovative ideas from research area of bioengeneering and tissue preservation.

Over 20 presentations and case studies focusing on the key areas of the biobanking industry including market access strategies, clinical development, commercialization, biostorage and biosampling-analytics at the Biobanking 2018

The ability of biobanks to aid in the collection, preparation, processing, handling, recovery, storage, and distribution of tissues and cell samples for therapeutic and research purposes are expected to result in this market’s impressive growth rate.

Geographically, the EMEA region is estimated to account for a market share of approximately 44% during the predicted period. The presence of a well-established biobanking system in the Nordic countries, such as Sweden, Norway, Denmark, Finland, and Iceland, is a significant factor that bolsters market growth in this region. This conference will gather biobanking leaders from the north, as well as from across the Atlantic, in order to zoom in the market prospects and understand the dynamics of this fast-paced growing industry.

The BioTech Pharma Summit: Biobanking 2018 is the leading event to get through  the biobanking’s ever-thriving market and convenes key stakeholders from the field,  and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing timely challenges and best practices for biobanking product success.

KEY PRACTICAL LEARNING POINTS

  • Present different types of biobanking and innovative models in precision medicine
  • Understand the opportunities and challenges of biosampling
  • Learn the latest technological methods and procedures for biopreservation, storage stability and validation, while naming evidence-based best practices
  • Explore new sample quality management systems, quality standards and accreditation
  • Learn how to maintain a sustainable infrastructure in biobanking
  • Debate the social and ethical challenges of biobanking for human research
  • Predict the market impact of biobanking in the next decade
  • Current market trends and future challenges for biobanking success
  • Biobanking development in emerging markets
  • Prognosis for the Global Biobanking market in an era of transformative new technologies
  • Commercial challenges and opportunities
  • Redesigning the biobanking business model
  • Clinical Trial Strategies in Biobanking and Drug Development
  • Determining the right investments & potential returns from Biobanks
  • Leading Biobank companies share their views and strategies on successful market penetration and learn to implement best practices through recent successful strategies and business models
  • Real time case studies

WHO SHOULD ATTEND?

The BioTech Pharma Summit (EPM Group) are exclusive events designed for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, along with highly esteemed members of academic and government institutions. Chief Executives, Executive Directors, Vice Presidents, Heads and Team Leaders and Managers including:

  • Biobanking Researchers
  • Biobanking Faculty Members
  • Medical Colleges
  • Biobanking Associations and Societies
  • Training Institutes
  • Cryo storage Companies
  • Data Provacy and Management Companies
  • Security Officers
  • Global Biobanking Companies
  • Business Developers
  • Biobanking investors
  • Lab Managers
  • Biopharmaceuticals and Biologics Researchers
  • Molecular Technologies
  • Intellectual property
  • Legislation and Policy Advice
  • Legislation and Policy Advice
  • Drug and Safety Assessment
  • Market Strategy
  • Biopharmaceuticals
  • Chief Scientific Officer
  • Clinical Immunology
  • Drug Safety Assessment & Risk Management
  • Population and Disease Based biobanks
  • Bioinnovation
  • Intellectual property
  • Regulatory Affairs
  • Health Economics
  • Principal Scientists
  • Process Control and Analytical Technologies
  • Quality Affairs/ Quality Control
  • Regulatory Affairs
  • Regulatory Compliance
  • Legal Affairs
  • R & D
  • New Product Development
  • Quality Affairs/Quality Control
  • Health Economics
  • Process Control and Analytical Technologies
Vice Director, Senior Consultant Pathologist at the University of Regensburg, Head of Biobanking at the University Medical Centre Mainz
Assistant Director of Biobank & Translational Research Core at Duke University Medical Center, USA
Head of the Spanish National Cancer Research Centre Biobank, and Former President of the ESBB, Spain
Chief Operating Officer at Biobank Graz, Austria
Director of Global Business Development at EPL Archives, Inc., USA
President and Medical Director of Ukraine Association of Biobank, Ukraine
Senior Director and General Cryo Solutions, Brooks Life Science Systems, USA
Vice-Dean of Faculty of Law at the New University of Lisbon, Portugal
Founder and Current Managing Director of Birka Biostorage, Sweden
Research Director at INSERM; Director at BIOBANQUES Infrastructure, France
Jennifer Cheeseman-Janes, MS, Senior Director, Biobank & Translational Research Core Department of Surgery at Duke University School of Medicine, USA
Managing Director of Biothéque Wallonie Bruxelles, Belgium
Head of Application Group at ASKION Gera, Germany
Project Director at Trans‑Hit Biomarkers Inc., Canada
Basic Package
1,995
Buy Ticket

Access to all Sessions

Access to all Networking Sessions

Cocktail Reception Included

Premium Package
3,550
Buy Ticket

Unique one-on-one meetings

Airport pick-up/drop-off

2 nights at the Hotel Venue

Basic Exhibition Package
3,550
Buy Ticket

3m2 exhibition space

1 Complementary ticket

25% discount for extra ticket

Premium Exhibition Package
6,995
Buy Ticket

6m2 exhibition space

1 Complementary ticket

2 nights at the Hotel Venue